Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocyte Transfusion | 19 | 2024 | 75 | 3.390 |
Why?
|
| Anemia | 15 | 2022 | 117 | 2.310 |
Why?
|
| Critical Illness | 19 | 2022 | 331 | 2.180 |
Why?
|
| Intensive Care Units, Pediatric | 15 | 2020 | 63 | 1.600 |
Why?
|
| Fluid Therapy | 4 | 2018 | 53 | 1.540 |
Why?
|
| Water-Electrolyte Imbalance | 2 | 2020 | 11 | 1.320 |
Why?
|
| Child | 30 | 2023 | 4238 | 1.220 |
Why?
|
| Respiration, Artificial | 8 | 2023 | 284 | 1.060 |
Why?
|
| Acute Lung Injury | 2 | 2023 | 39 | 1.050 |
Why?
|
| Neuromuscular Blockade | 2 | 2023 | 9 | 0.980 |
Why?
|
| Water-Electrolyte Balance | 3 | 2020 | 19 | 0.900 |
Why?
|
| Critical Care | 17 | 2022 | 404 | 0.880 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 49 | 0.870 |
Why?
|
| Ventilator-Induced Lung Injury | 2 | 2013 | 11 | 0.850 |
Why?
|
| Hemostatics | 1 | 2022 | 26 | 0.810 |
Why?
|
| Hemoglobins | 4 | 2023 | 139 | 0.810 |
Why?
|
| Delirium | 1 | 2023 | 56 | 0.800 |
Why?
|
| Respiratory Insufficiency | 3 | 2019 | 147 | 0.790 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 77 | 0.620 |
Why?
|
| Phlebotomy | 2 | 2017 | 8 | 0.540 |
Why?
|
| Infant | 11 | 2022 | 1507 | 0.530 |
Why?
|
| Child, Preschool | 11 | 2020 | 1812 | 0.510 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2015 | 8 | 0.510 |
Why?
|
| Evidence-Based Medicine | 13 | 2022 | 455 | 0.450 |
Why?
|
| Humans | 35 | 2024 | 58820 | 0.430 |
Why?
|
| Hemorrhage | 3 | 2022 | 276 | 0.430 |
Why?
|
| Platelet Transfusion | 4 | 2022 | 13 | 0.360 |
Why?
|
| Infant, Newborn | 7 | 2022 | 1299 | 0.340 |
Why?
|
| Consensus Development Conferences as Topic | 2 | 2018 | 14 | 0.320 |
Why?
|
| Pediatrics | 2 | 2020 | 250 | 0.270 |
Why?
|
| Sepsis | 2 | 2022 | 278 | 0.270 |
Why?
|
| Self Report | 2 | 2019 | 364 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 701 | 0.250 |
Why?
|
| Adolescent | 7 | 2020 | 5862 | 0.250 |
Why?
|
| Blood Banks | 1 | 2024 | 9 | 0.230 |
Why?
|
| Heart Defects, Congenital | 2 | 2023 | 81 | 0.200 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2022 | 5 | 0.200 |
Why?
|
| Liver Failure, Acute | 1 | 2022 | 16 | 0.200 |
Why?
|
| Transfusion Reaction | 2 | 2018 | 46 | 0.190 |
Why?
|
| Consensus | 2 | 2023 | 189 | 0.190 |
Why?
|
| Neoplasms | 2 | 2022 | 1220 | 0.170 |
Why?
|
| Liver Transplantation | 1 | 2022 | 185 | 0.170 |
Why?
|
| Education, Distance | 1 | 2020 | 34 | 0.170 |
Why?
|
| Thalassemia | 1 | 2018 | 4 | 0.160 |
Why?
|
| Anemia, Hemolytic | 1 | 2018 | 11 | 0.160 |
Why?
|
| Shock, Hemorrhagic | 1 | 2018 | 19 | 0.160 |
Why?
|
| Shock | 1 | 2018 | 31 | 0.160 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 23 | 0.160 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 65 | 0.150 |
Why?
|
| Health Personnel | 1 | 2021 | 336 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2018 | 146 | 0.150 |
Why?
|
| Graft vs Host Disease | 1 | 2018 | 99 | 0.150 |
Why?
|
| Male | 9 | 2020 | 27258 | 0.150 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 40 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2014 | 2428 | 0.140 |
Why?
|
| Female | 9 | 2020 | 30545 | 0.140 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 123 | 0.130 |
Why?
|
| Diet Therapy | 1 | 2015 | 14 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2015 | 55 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 662 | 0.120 |
Why?
|
| Conscious Sedation | 1 | 2015 | 49 | 0.120 |
Why?
|
| Patient Care Planning | 1 | 2015 | 84 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2020 | 669 | 0.120 |
Why?
|
| Erythrocyte Count | 3 | 2018 | 14 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 2442 | 0.120 |
Why?
|
| Guideline Adherence | 1 | 2016 | 294 | 0.120 |
Why?
|
| Incidence | 2 | 2020 | 1226 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2015 | 5921 | 0.110 |
Why?
|
| Pain Management | 1 | 2015 | 143 | 0.110 |
Why?
|
| Acute Disease | 1 | 2015 | 649 | 0.110 |
Why?
|
| Length of Stay | 1 | 2016 | 759 | 0.110 |
Why?
|
| Boston | 1 | 2014 | 325 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2020 | 694 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2016 | 890 | 0.100 |
Why?
|
| Bayes Theorem | 1 | 2012 | 108 | 0.100 |
Why?
|
| Blood Component Transfusion | 2 | 2022 | 8 | 0.100 |
Why?
|
| Blood Specimen Collection | 1 | 2012 | 19 | 0.100 |
Why?
|
| Plasma | 2 | 2022 | 33 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 38 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2012 | 254 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 261 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 708 | 0.090 |
Why?
|
| Patient Safety | 1 | 2012 | 234 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 1437 | 0.080 |
Why?
|
| Clinical Decision-Making | 2 | 2018 | 137 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 196 | 0.070 |
Why?
|
| Risk Factors | 2 | 2015 | 4971 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 431 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2012 | 1893 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2002 | 19 | 0.050 |
Why?
|
| Receptors, Glutamate | 1 | 2002 | 18 | 0.050 |
Why?
|
| Calcium Channels, L-Type | 1 | 2002 | 24 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 56 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 3071 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 201 | 0.050 |
Why?
|
| Research | 1 | 2022 | 190 | 0.040 |
Why?
|
| Decision Making | 1 | 2023 | 382 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2002 | 190 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 93 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 259 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 148 | 0.040 |
Why?
|
| Simulation Training | 1 | 2020 | 58 | 0.040 |
Why?
|
| IgA Deficiency | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2018 | 7 | 0.040 |
Why?
|
| Vital Signs | 1 | 2018 | 11 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 34 | 0.040 |
Why?
|
| Decision Trees | 1 | 2018 | 50 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 187 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 72 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 4270 | 0.040 |
Why?
|
| Hemoglobinometry | 1 | 2017 | 2 | 0.040 |
Why?
|
| Missouri | 1 | 2017 | 12 | 0.040 |
Why?
|
| Pediatric Nursing | 1 | 2017 | 11 | 0.040 |
Why?
|
| Utilization Review | 1 | 2017 | 31 | 0.040 |
Why?
|
| Hematocrit | 1 | 2017 | 33 | 0.040 |
Why?
|
| Blood Volume | 1 | 2017 | 42 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2017 | 42 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 1090 | 0.040 |
Why?
|
| Inservice Training | 1 | 2017 | 81 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 819 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 853 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1561 | 0.030 |
Why?
|
| Survivors | 1 | 2016 | 148 | 0.030 |
Why?
|
| Positive-Pressure Respiration | 1 | 2015 | 45 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2016 | 93 | 0.030 |
Why?
|
| Adult | 2 | 2023 | 15596 | 0.030 |
Why?
|
| New England | 1 | 2015 | 267 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2015 | 118 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 246 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 925 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 769 | 0.030 |
Why?
|
| Biometry | 1 | 2008 | 11 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3544 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 107 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 249 | 0.020 |
Why?
|
| Patients | 1 | 2008 | 102 | 0.020 |
Why?
|
| Research Design | 1 | 2008 | 561 | 0.020 |
Why?
|
| Kainic Acid | 1 | 2002 | 5 | 0.010 |
Why?
|
| Nifedipine | 1 | 2002 | 13 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2002 | 30 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2002 | 47 | 0.010 |
Why?
|
| Electron Transport | 1 | 2002 | 28 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 54 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2002 | 229 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 252 | 0.010 |
Why?
|
| Cerebellum | 1 | 2002 | 92 | 0.010 |
Why?
|
| Iron | 1 | 2002 | 144 | 0.010 |
Why?
|
| Cell Death | 1 | 2002 | 265 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 193 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 547 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 327 | 0.010 |
Why?
|
| Rats | 1 | 2002 | 1901 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2002 | 2090 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 19483 | 0.000 |
Why?
|